Citation Impact
Citing Papers
Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption
2006 StandoutNobel
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
Neural Tube Defects along the Texas-Mexico Border, 1993-1995
1999
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Analysis of select folate pathway genes,PAX3, and humanT in a midwestern neural tube defect population
1999
Delayed graft function in kidney transplantation
2004 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Current perspectives on the genetic causes of neural tube defects
2006
A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
2011 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Maternal Obesity, Gestational Diabetes, and Central Nervous System Birth Defects
2004
Sjögren's syndrome
2005 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Regional differences in morphogenesis of the neuroepithelium suggest multiple mechanisms of spinal neurulation in the mouse
1996
Renal-Artery Stenosis
2001 Standout
Epidemiological analysis of multi-site closure failure of neural tube in humans
1996
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Toward understanding the genetic basis of neural tube defects
2007
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Histological-hemodynamic correlation in cirrhosis—a histological classification of the severity of cirrhosis
2005
Pathophysiology, prevention, and potential treatment of neural tube defects
2000
Neural-Tube Defects
1999 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Hepatic circulation: Potential for therapeutic intervention
1990
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
1995
Acceptance and Commitment Therapy: Model, processes and outcomes
2005 Standout
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Angiotensin II induces superoxide anion production by mesangial cells
1998
Spina bifida
2004
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Enrolment into Birth to Ten (BTT): population and sample characteristics
1995
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome
2006
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.
1995
Ren1c Homozygous Null Mice Are Hypotensive and Polyuric, but Heterozygotes Are Indistinguishable from Wild-Type
2004 StandoutNobel
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease
2005
Antisense Oligonucleotide Down-Regulation of E-Cadherin in the Yolk Sac and Cranial Neural Tube Malformations1
1995
Mouse models for neural tube closure defects
2000
Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody-Mediated Damage Despite Lack of C4d Staining
2009
The renin-angiotensin-aldosterone system: a specific target for hypertension management
1999
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Antibody-mediated organ-allograft rejection
2005
Maternal Overweight and Obesity and the Risk of Congenital Anomalies
2009 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Antibody-Mediated Rejection in Renal Allografts
2006
A Controlled Trial of Combined Therapy for Newly Diagnosed Severe Childhood IgA Nephropathy
1999
Acute Humoral Rejection in Kidney Transplantation
2002
Spina bifida phenotypes in infants or fetuses of obese mothers
2000
Folate and human reproduction
2006
Prenatally diagnosed neural tube defects: Ultrasound, chromosome, and autopsy or postnatal findings in 212 cases
1998
Infection in Solid-Organ Transplant Recipients
2007 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
PLASMA EXCHANGE AND TACROLIMUS-MYCOPHENOLATE RESCUE FOR ACUTE HUMORAL REJECTION IN KIDNEY TRANSPLANTATION1
1998
Capillary C4d Deposition in Kidney Allografts
2002
Sjögren's syndrome associated with systemic lupus erythematosus: Clinical and laboratory profiles and comparison with primary Sjögren's syndrome
2004
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Developmental potential in the first 5 years for children in developing countries
2007 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects
2000
Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure
2009 StandoutNobel
ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1
2001
Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial
2005
Prevention of Neural-Tube Defects with Folic Acid in China
1999 Standout
Transition from Birth to Ten to Birth to Twenty: the South African cohort reaches 13 years of age
2004
Mechanisms of neural tube closure and defects
1998
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme
1997 StandoutNobel
BIOLOGICAL FUNCTIONS OF ANGIOTENSIN AND ITS RECEPTORS
1997
The significance of the circulating cancer cell
1975
Mycotoxins
2003 Standout
Sequential analysis of hepatic carcinogenesis: the comparative architecture of preneoplastic, malignant, prenatal, postnatal and regenerating liver
1979
NAD(P)H Oxidase
2000 Standout
Epidemiology of neural tube defects
1998
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Vasoactive hormones and renal sclerosis
1996
Liver Regeneration
1997 StandoutScience
The pathogenesis of cancer metastasis
1980 StandoutNature
Delayed Graft Function in Renal Transplantation: Etiology, Management and Long-term Significance
1996
Mechanisms of Diabetic Complications
2013 Standout
Morphologic studies of the liver cell dysplasia
1983
Gene Targeting Approaches to Analyzing Hypertension
1999 StandoutNobel
Looking for causes of neural tube defects: where does the environment fit in?
1995
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
Animal models of neural tube defects
1998
The Role of Fat-Storing Cells in Disse Space Fibrogenesis in Alcoholic Liver Disease
1983
Regulation of Sodium Balance and Blood Pressure by the AT1AReceptor for Angiotensin II
2000 StandoutNobel
Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
1985
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
1998
Works of Susan Ritchie being referenced
Long-term Benefits of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Severe Immunoglobulin A Nephropathy: A Comparison to Patients Receiving Treatment With Other Antihypertensive Agents and to Patients Receiving No Therapy
1994
THE SIGNIFICANCE OF THE ANTI-CLASS I ANTIBODY RESPONSE
1990
Evidence for multi‐site closure of the neural tube in humans
1993
A controlled trial of cyclosporine in patients with progressive membranous nephropathy
1995
Tumour cells in the blood.
1959
The pathology of Armanni-Ebstein diabetic nephropathy.
2000
Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat
1981
Kidney Biopsy in SLE. I. A Clinical-Morphologic Evaluation
1989
Benign liver cell tumors.Classification and ultrastructural pathology
1973
Subject loss and its implications for a high-risk population
1989
Maternal adjustment following preterm birth: Contributions of experiential avoidance
2005